This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Oct;288(16):2042-3.

doi: 10.1001/jama.288.16.2042.

Homocysteine and coronary heart disease: how great is the hazard?

Peter W F Wilson

PMID: 12387658
DOI: 10.1001/jama.288.16.2042

Editorial

Homocysteine and coronary heart disease: how great is the hazard?

Peter W F Wilson. JAMA. 2002 Oct.

. 2002 Oct;288(16):2042-3.

doi: 10.1001/jama.288.16.2042.

Author

Peter W F Wilson

PMID: 12387658
DOI: 10.1001/jama.288.16.2042

No abstract available

PubMed Disclaimer

Comment on

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
Homocysteine Studies Collaboration. Homocysteine Studies Collaboration. JAMA. 2002 Oct 23-30;288(16):2015-22. doi: 10.1001/jama.288.16.2015. JAMA. 2002. PMID: 12387654
MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. Klerk M, et al. JAMA. 2002 Oct 23-30;288(16):2023-31. doi: 10.1001/jama.288.16.2023. JAMA. 2002. PMID: 12387655

Similar articles

[Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
Blankenberg S, Rupprecht HJ, Peetz D, Bickel C, Hofman KP, Tiret L, Meyer J. Blankenberg S, et al. Dtsch Med Wochenschr. 2002 Apr 5;127(14):729-35. doi: 10.1055/s-2002-24402. Dtsch Med Wochenschr. 2002. PMID: 11935469 German. No abstract available.
Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.
Virgos C, Joven J, Simó JM, Vilella E, Camps J, Arcelus R, Blanco-Vaca F, Figuera L, Martorell L. Virgos C, et al. Clin Biochem. 2000 Aug;33(6):509-12. doi: 10.1016/s0009-9120(00)00151-x. Clin Biochem. 2000. PMID: 11074245 No abstract available.
Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease.
Wilcken DE, Wang XL, Wilcken B. Wilcken DE, et al. Circulation. 1997 Oct 21;96(8):2738-40. Circulation. 1997. PMID: 9355925 No abstract available.
Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
Rozen R. Rozen R. Thromb Haemost. 1997 Jul;78(1):523-6. Thromb Haemost. 1997. PMID: 9198208 Review. No abstract available.
Methylene tetrahydrofolate reductase gene and coronary artery disease.
Iqbal MP, Frossard PM. Iqbal MP, et al. J Pak Med Assoc. 2003 Jan;53(1):33-6. J Pak Med Assoc. 2003. PMID: 12666851 Review. No abstract available.

See all similar articles

Cited by

Hyperhomocysteinemia is an independent predictor of sub-clinical carotid vascular damage in subjects with grade-1 hypertension.
Mazza A, Cuppini S, Schiavon L, Zuin M, Ravenni R, Balbi G, Montemurro D, Opocher G, Pelizzo MR, Colletti PM, Rubello D. Mazza A, et al. Endocrine. 2014 Jun;46(2):340-6. doi: 10.1007/s12020-013-0063-3. Epub 2013 Oct 3. Endocrine. 2014. PMID: 24197804
Risk factors in coronary atherosclerosis athero-inflammation: the meeting point.
Altman R. Altman R. Thromb J. 2003 Jul 17;1(1):4. doi: 10.1186/1477-9560-1-4. Thromb J. 2003. PMID: 12904259 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems